Corixa [CRXA] - cancer vaccines | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Corixa [CRXA] - cancer vaccines

An SI Board Since March 1998

Posts	SubjectMarks	Bans	Symbol
222	31	0	CRXA

Emcee: Andreas Helke	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
97	IDEC Pharmaceuticals Brings Separate Patent Suits Against Corixa and Glaxo Smith	sim1	-	9/12/2001
96	FDA Advisory Committee Panel Recommends Approval of ZEVALIN for Treatment of Cer	sim1	-	9/12/2001
95	Corixa and GlaxoSmithKline File Suit Against IDEC Pharmaceuticals Corporation fo	sim1	-	9/12/2001
94	Corixa and GlaxoSmithKline Announce the Completed Submission of Bexxar Data and	sim1	-	9/7/2001
93	Corixa receives multiple U.S. patents in oncology programs	sim1	-	8/9/2001
92	4:03 pm Eastern Time SEATTLE--(BW HealthWire)--August 9, 2001-- Corixa Corporati	nigel bates	-	8/9/2001
91	Corixa and GlaxoSmithKline announce submission of Bexxar data and documentation	sim1	-	8/9/2001
90	Newsweek article: My Life as a Guinea Pig Clinical trials are inherently risk	Micawber	-	8/2/2001
89	Pacific Growth Equities Morning Call Summary for July 3, 2001 07/03/01 07:45	sim1	-	7/4/2001
88	V1: I suppose it will help their case when the subgroup is something like 80% o	Micawber	-	6/22/2001
87	TOKYO, June 21 /PRNewswire/ -- Kirin Brewery Co., Ltd. and Corixa Corporation (N	nigel bates	-	6/22/2001
86	Brian, sub-group analysis around a specific gene. This is not necessarily bad. T	Vector1	-	6/21/2001
85	Subgroup analysis. The FDA will be real excited about that.	Micawber	-	6/21/2001
84	Corixa provides update on late stage clinical programs	sim1	-	6/20/2001
83	<i>With great ambivilence and I still own shares in my PA</i> You&#	Micawber	-	6/14/2001
82	SEATTLE--(BW HealthWire)--June 11, 2001--Corixa Corporation (Nasdaq:CRXA - news)	nigel bates	-	6/11/2001
81	<<I was surprised that you soured on the company >> With great ambiv	Vector1	-	6/5/2001
80	Sure that the rise has a lot to do with sector strength and crxa vaccine program	ewolf	-	6/5/2001
79	I have always like Bexxar. I think it is an excellent drug and has $300plus sale	Vector1	-	6/5/2001
78	Here we are more than a couple of months later with a significant rise in the st	ewolf	-	6/4/2001
77	ASCO news from Yahoo Novel Strategies Boost Outcomes of Bone Marrow Transplanta	sim1	-	5/15/2001
76	IDEC Sees the Light at the End of the Zevalin Tunnel By Ad	sim1	-	5/11/2001
75	IDEC Meets the Street but Sees Approval Delay on Drug By A	sim1	-	4/19/2001
74	April 5, 2001--Corixa Corporation (Nasdaq:CRXA - news), a developer of immunothe	nigel bates	-	4/5/2001
73	<remember that 6-12 month lead for Bexxar? > Yes, it's like a dream	LLCF	-	3/26/2001

Go to reply# or date (mm/dd/yy):